Stock Fundamentals

Company Information

Company Name
Veracyte Inc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN: US92337F1075
CIK: 0001384101
CUSIP: 92337F107
Currency: USD
Full Time Employees: 755
Phone: 650 243 6300
Fiscal Year End: December
IPO Date: Oct 30, 2013
Description:

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Address:

6000 Shoreline Court, South San Francisco, CA, United States, 94080

Directors & Officers

Name Title Year Born
Mr. Marc A. Stapley CEO & Director 1970
Ms. Rebecca Chambers Executive VP & CFO 1978
Dr. Phillip G. Febbo M.D. Chief Scientific & Medical Officer 1966
Ms. Annie McGuire Executive VP, General Counsel & Head of Market Access 1981
Dr. John Leite Ph.D. Global Chief Commercial Officer 1972
Dr. Keith Gligorich Ph.D. Senior Vice President of Global Operations NA
Mr. Jonathan Wygant VP & Chief Accounting Officer 1971
Dr. Kevin Richard Haas Ph.D. Chief Development and Technology Officer 1985
Mr. Steven French Senior VP & Chief Information Officer NA
Ms. Kelly Gura Director of Investor Relations NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 04, 2026 John Leite N/A Sale 5.26K $35.19 $185.10K
Mar 04, 2026 Marc Stapley N/A Sale 45.52K $35.97 $1.64M
Mar 04, 2026 Rebecca Chambers N/A Sale 18.34K $36.14 $662.84K
Mar 04, 2026 Annie Mcguire N/A Sale 6.66K $35.55 $236.69K
Mar 03, 2026 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $35.08 N/A
Dec 16, 2025 Annie Mcguire N/A Sale 10.74K $43.13 $463.17K
Dec 05, 2025 Karin Eastham N/A Sale 20.00K $45.45 $909.00K
Dec 04, 2025 Annie Mcguire N/A Sale 1.42K $47.30 $67.26K
Dec 04, 2025 John Leite N/A Sale 1.28K $47.51 $60.72K
Dec 04, 2025 Marc Stapley N/A Sale 7.67K $47.09 $361.09K
Dec 04, 2025 Rebecca Chambers N/A Sale 13.28K $46.84 $621.94K
Nov 25, 2025 Evan/ Fa Jones N/A Sale 1.11K $50.25 $55.58K
Nov 25, 2025 John Leite N/A Sale 2.81K $50.00 $140.40K
Nov 20, 2025 Jens Holstein N/A Sale 10.00K $42.36 $423.60K
Nov 12, 2025 Gilbert Ray Cisneros, Jr. N/A Sale N/A $42.30 N/A
Nov 05, 2025 Annie Mcguire N/A Sale 6.47K $40.00 $258.64K
Nov 05, 2025 Evan/ Fa Jones N/A Sale 43.20K $45.06 $1.95M
Nov 05, 2025 Karin Eastham N/A Sale 9.67K $40.02 $387.15K
Nov 05, 2025 Rebecca Chambers N/A Sale 7.00K $41.00 $287.00K
Oct 06, 2025 Phillip G Febbo N/A Sale 8.35K $36.02 $300.73K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 13.17M Mar 31, 2026 16.51% $0.01 0.33%
Vanguard Group Inc 8.50M Dec 31, 2025 10.66% $0.01 0.00%
FMR Inc 7.76M Mar 31, 2026 9.73% $0.01 35.30%
Artisan Partners Limited Partnership 5.50M Mar 31, 2026 6.89% $0.28 -12.24%
State Street Corp 5.04M Mar 31, 2026 6.32% $0.01 15.65%
ARK Investment Management LLC 3.05M Mar 31, 2026 3.83% $0.76 -21.45%
Dimensional Fund Advisors, Inc. 2.88M Mar 31, 2026 3.61% $0.02 2.88%
Wellington Management Company LLP 2.56M Mar 31, 2026 3.21% $0.02 25.63%
First Trust Advisors L.P. 2.12M Mar 31, 2026 2.65% $0.05 64.94%
Geode Capital Management, LLC 1.96M Mar 31, 2026 2.45% $0.00 2.96%
Bank of America Corp 1.45M Mar 31, 2026 1.82% $0.00 14.72%
GW&K Investment Management, LLC 1.44M Mar 31, 2026 1.80% $0.41 26.07%
Fuller & Thaler Asset Management Inc 1.41M Mar 31, 2026 1.77% $0.15 -48.81%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 1.37M Mar 31, 2026 1.72% $1.18 -12.00%
The Goldman Sachs Group Inc 1.28M Mar 31, 2026 1.60% $0.00 6.86%
Sumitomo Mitsui Trust Group Inc 1.06M Mar 31, 2026 1.32% $0.02 -16.08%
Amova Asset Management Americas, Inc 1.05M Mar 31, 2026 1.31% $0.48 -16.92%
William Blair Investment Management, LLC 989.69K Mar 31, 2026 1.24% $0.11 25.21%
Iron Triangle Partners LP 980.39K Dec 31, 2025 1.23% $4.72 102.14%
Northern Trust Corp 929.50K Mar 31, 2026 1.16% $0.00 -6.32%

Shares Statistics

Shares Outstanding: 79.79M
Shares Float: 79.37M
% Insiders: 50.50%
% Institutions: 11,328.40%
Short % Float: 12.74%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 4.82M 6.04% ▲ 0.02% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 2.52M 3.16% ▲ 0.34% Apr 30, 2026
3 First Trust NYSE Arca Biotech ETF 2.42M 3.03% ▼ 0.46% Apr 30, 2026
4 State Street® SPDR® S&P® Biotech ETF 2.19M 2.74% ▼ 0.71% Apr 30, 2026
5 iShares Russell 2000 ETF 1.84M 2.31% ▲ 0.85% Apr 30, 2026
6 Vanguard Small Cap Index 1.83M 2.30% ▼ 0.15% Apr 30, 2026
7 ARK Disruptive Innovation Full Composite 1.82M 2.28% ▼ 26.39% Mar 31, 2026
8 Vanguard Explorer Inv 1.77M 2.22% ▲ 10.08% Mar 31, 2026
9 ARK Innovation ETF 1.76M 2.21% ▼ 6.80% Apr 30, 2026
10 Fidelity Select Health Care 1.36M 1.70% ▲ 32.02% Mar 31, 2026

Valuation Metrics

Enterprise Value: $3.44B
Trailing P/E: 45.08
Forward P/E: 28.01

Financial Highlights

Market Cap: $3.89B
EBITDA: $104.21M
P/E Ratio: $45.08
PEG Ratio: $0.00
Book Value: $16.50
Earnings/Share: $1.08
Profit Margin: 16.25%
Operating Margin: 16.28%
ROA (TTM): 3.76%
ROE (TTM): 6.93%
Revenue (TTM): $541.74M
Revenue/Share (TTM): $6.86
Earnings Growth (YOY): 288.90%
Revenue Growth (YOY): 21.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.15x 0.00x 0.07x 74,150.00x 0.05x
2024-12-31 4.73x 0.01x 0.10x 8,071.00x 0.15x
2023-12-31 4.66x 0.00x 0.06x -5,719.67x -0.10x
2022-12-31 3.97x 0.00x 0.07x -207.48x -0.58x
2021-12-31 3.79x 0.00x 0.08x -339.85x -0.08x
2020-12-31 22.39x 0.01x 0.08x -154.54x -0.09x
2019-12-31 10.74x 0.01x 0.13x -22.34x -0.27x
2018-12-31 7.42x 0.32x 0.34x -11.33x -1.48x
2017-12-31 4.48x 1.36x 0.53x -5.37x -2.12x
2016-12-31 6.38x 0.86x 0.41x -10.45x -2.03x
2015-12-31 3.26x 0.20x 0.32x -88.53x -0.31x
2014-12-31 2.53x 0.24x 0.36x -66.07x -0.34x
2013-12-31 4.97x 0.09x 0.29x -99.45x -0.20x
2012-12-31 1.82x 0.00x 0.74x N/A 0.00x
2011-12-31 4.56x 0.00x 0.18x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about VCYT.US!